FDA.reportPublic FDA data

Viibryd 40 MG Oral Tablet

RxCUI
1086786
RxNorm name
Viibryd 40 MG Oral Tablet
Display name
Viibryd 40 MG Oral Tablet
Full name
Viibryd 40 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VIIBRYDVILAZODONE HYDROCHLORIDEAllergan, Inc.4c55ccfb-c4cf-11df-851a-0800200c9a662023-10-01Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1086786

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4c55ccfb-c4cf-11df-851a-0800200c9a66Viibryd 40 MG Oral Tablet [PSN] · vilazodone hydrochloride 40 MG Oral Tablet [Viibryd] [SBD] · Viibryd 40 MG Oral Tablet [SY]334These highlights do not include all the information needed to use VIIBRYD ® safely and effectively. See full prescribing information for VIIBRYD . VIIBRYD ( vilazodone hydrochloride ) t ablets , for oral use Initial U.S. Approval: 201 120231001